Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1310072

registered interest
date	19/04/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the rate of positive swab tests for covid-19 among people who have received both doses of a vaccination.
tabling member constituency	Altrincham and Sale West
tabling member printed	Sir Graham Brady
uin	183067
answer	answer is ministerial correction date of answer 22/04/2021 answer text <p>Data on effectiveness of two doses of COVID-19 vaccine will be published in due course, once larger numbers of the population have been vaccinated with two doses and sufficient time has elapsed for an effect to be monitored.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/04/2021 15:25:17 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	435 label Biography information for Sir Graham Brady

1309776

registered interest
date	16/04/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have received a covid-19 vaccination in Bromsgrove constituency on the most recent date for which information is available.
tabling member constituency	Bromsgrove
tabling member printed	Sajid Javid
uin	182035
answer	answer is ministerial correction date of answer 22/04/2021 answer text <p>On 15 April 2021 NHS England and Improvement published data showing that between 8 December 2020 and 11 April 2021, 56,146 people in Bromsgrove had received at least one dose of a COVID-19 vaccine. This data is published at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/04/2021 15:22:53 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3945 label Biography information for Sir Sajid Javid

1309797

registered interest
date	16/04/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 March 2019 to Question 166586 on Coronavirus: Vaccination, since the Joint Committee on Vaccination and Immunisation advised that local teams should consider a universal offer to adults experiencing homelessness and rough sleeping alongside people in priority group six, how many homeless people in the UK have received a covid-19 vaccine.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	182107
answer	answer is ministerial correction date of answer 26/04/2021 answer text <p>Data is not available in the format requested.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/04/2021 15:51:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4811 label Biography information for Navendu Mishra

1309801

registered interest
date	16/04/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many Oxford/AstraZenica vaccines were exported from the UK to Australia in late February and early March 2021.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	182110
answer	answer is ministerial correction date of answer 27/04/2021 answer text <p>The details of any commercial vaccine supply agreements between national governments and AstraZeneca are a matter for those two parties.</p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 27/04/2021 16:04:47 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4811 label Biography information for Navendu Mishra

1309375

registered interest
date	15/04/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prisons and Probation: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 March 2021 to Question 138422 and the Answer of 16 March 2021 to Question 154909, if he will publish recent data on the vaccination rates for (a) directly employed prison staff, (b) non-directly employed people who work within prisons, (c) probation staff who have direct contact with service users and (d) prisoners.
tabling member constituency	West Ham
tabling member printed	Ms Lyn Brown
uin	181215
answer	answer is ministerial correction date of answer 27/04/2021 answer text <p>We do not currently centrally hold data on the vaccination rates for directly employed prison staff, non-directly employed people who work within prisons or probation staff.</p><p> </p><p>As of 19 April 2021 we have administered 23,281 first doses to prisoners eligible for vaccination during phase one. This represents an estimated 85% of eligible prisoners. In addition, 780 prisoners have received second doses which is 3.4% of the first dose total and includes some prisoners having a second dose in prison after a first dose in the community.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 27/04/2021 15:31:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1583 label Biography information for Ms Lyn Brown

1309476

registered interest
date	15/04/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to (a) the definition of severe asthma set out in paragraph 1.2 of the NICE 2020 publication, COVID-19 rapid guideline: severe asthma and (b) the article by Bloom et al published in The Lancet on 4 March 2021, what assessment his Department has made of the potential merits of prioritising all asthmatics in (i) phase 2 and (ii) future phases including booster shots of the covid-19 vaccine rollout; and whether the JCVI considered the NICE guidelines on covid-19 and severe asthma when setting out the approach to covid-19 vaccination roll out in the UK.
tabling member constituency	North Norfolk
tabling member printed	Duncan Baker
uin	181447
answer	answer is ministerial correction date of answer 26/04/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) considered data from OpenSAFELY and QCOVID in determining the risk of COVID-19 in those with asthma and in determining which individuals with asthma were at significant risk of mortality from COVID-19 in phase one of the COVID-19 vaccination programme. The JCVI concluded that only a subset of those with asthma are at clinically higher risk from COVID-19. This group is defined by data from OpenSAFELY and QCOVID as adults with asthma who require continuous or repeated use of systemic steroids or with previous exacerbations requiring hospital admission. The National Institute for Health and Care Excellence’s guideline Bloom et al were not used.</p><p>For phase two, the JCVI concluded that there is good evidence that the risks of hospitalisation and critical care admission from COVID-19 increase with age. The JCVI advised that the offer of vaccination during phase two is age-based starting with the oldest adults first. The JCVI has not advised prioritisation of any sub-groups and is currently considering the need for and timing of future phases and booster doses of COVID-19 vaccines. Their advice will be published in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/04/2021 16:06:02 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 98078 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4784 label Biography information for Duncan Baker

1309524

registered interest
date	15/04/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Electric Vehicles: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what plans his Department has to support the domestic exploitation of raw materials for the electric car industry.
tabling member constituency	Morley and Outwood
tabling member printed	Andrea Jenkyns
uin	181348
answer	answer is ministerial correction date of answer 23/04/2021 answer text <p>The Government recognises the importance of critical raw minerals for the development of zero emission vehicles. We are committed to building an agile, innovative and cost-competitive supply chain for these vehicles in the UK to support our commitment to end the sale of new petrol and diesel cars and vans by 2030.</p><p> </p><p>Batteries for electric vehicles require a range of critical materials, including lithium. Government has supported a number of initiatives to find and use lithium in the UK, including work in Cornwall to develop lithium extraction plants.</p><p> </p><p>The Government is also investing £318m in the Faraday Battery Challenge to put the UK at the global forefront of the design, development, manufacturing, and recycling of electric batteries. In addition, the Automotive Transformation Fund (ATF) aims to develop and embed at pace the next generation of cutting-edge zero emission automotive technologies in the UK. £500m of funding for the ATF will be made available in the next four years for businesses across the UK to fund investments across the whole supply chain.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/04/2021 14:40:47 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4490 label Biography information for Dame Andrea Jenkyns

1309527

registered interest
date	15/04/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Vaccination: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps the Department is taking to support British domestic capacity to produce future vaccines.
tabling member constituency	Morley and Outwood
tabling member printed	Andrea Jenkyns
uin	181349
answer	answer is ministerial correction date of answer 23/04/2021 answer text <p>The Government has invested over £300 million to secure and scale-up the UK’s manufacturing capabilities to be able to respond to this pandemic, as well as any future pandemics. This includes:</p><p>a) Facilities that have come online:</p><ul><li>£65.5 million for the early manufacture of the University of Oxford/AstraZeneca vaccine;</li><li>£8.75 million for the set-up of the rapid deployment facility at Oxford Biomedica in Oxfordshire;</li><li>£8.6 million to the Centre of Process Innovation to develop GMP-ready mRNA manufacturing capability;</li><li>£4.7 million for skills training through the Advanced Therapies Skills Training Network, which will be delivered through both virtual and physical centres; and</li><li>Funding for fill and finish through a contract with Wockhardt in Wrexham, North Wales, which is currently providing fill and finish capabilities to the University of Oxford/AstraZeneca vaccine.</li></ul><p>b) Facilities that will come online later this year, to help provide longer-term UK capacity:</p><ul><li>£140.6 million to accelerate the completion and expanded role of the Vaccines Manufacturing Innovation Centre in Oxfordshire;</li><li>£127 million for the Cell and Gene Therapy Catapult in Braintree, Essex; and</li><li>Funding for the expansion of the Valneva factory in Livingston, Scotland.</li></ul> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/04/2021 13:42:47 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4490 label Biography information for Dame Andrea Jenkyns

1308939

registered interest
date	14/04/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	British Students Abroad: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an announcement on the covid-19 vaccine priority applicable to students planning to study abroad in the 2021-22 academic year; and if he will make it his policy that those students will be eligible to receive both doses of that vaccine prior to the start of that academic year.
tabling member constituency	Tonbridge and Malling
tabling member printed	Tom Tugendhat
uin	181058
answer	answer is ministerial correction date of answer 23/04/2021 answer text <p>There are no plans to do so.</p><p>On 13 April, the Joint Committee on Vaccination and Immunisation (JCVI) published their final advice on phase two of the COVID-19 vaccination programme, which was to continue with an age-based programme. Students planning to study abroad in the 2021-22 academic year will receive their vaccinations in line with that advice when they become eligible because of their age, individual clinical risk factors, or because they are students who work as frontline health or social care workers or are unpaid carers. In line with other adults in the United Kingdom, they can expect to receive their first dose by the end of July 2021 and their second dose within 12 weeks of their first.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/04/2021 08:45:32 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4462 label Biography information for Tom Tugendhat

1308990

registered interest
date	14/04/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that all GPs are aware of the update to JCVI guidance on prioritisation of adults for the covid-19 living with immunocompromised clinically extremely vulnerable people.
tabling member constituency	Nottingham North
tabling member printed	Alex Norris
uin	181092
answer	answer is ministerial correction date of answer 22/04/2021 answer text <p>The National Health Service has written to all general practitioner practices setting out how vaccines will be offered to this group and how eligible individuals are to be identified. A separate ‘Operational Guide’ has been created setting out more details and how the NHS plans to maximise uptake in this group. The NHS has also written to all Medical Directors setting out the steps needed to identify immunosuppressed individuals in secondary care.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/04/2021 09:17:06 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 97235 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4641 label Biography information for Alex Norris